Terminated NA INTERVENTIONAL 2-arm NCT00915928

Chronic Subdural Hematoma - Reduction of Recurrence by Treatment With Angiotensin Converting Enzyme Inhibitors (KSDH)

Sponsor: Alice Brenaa Foundation

Updated 9 times since 2017 Last updated: Aug 18, 2020 Started: Jul 31, 2009 Primary completion: May 31, 2012 Completion: Jun 30, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

No effect of the ACE inhibitor evaluated halfway in the study

Other Hematoma, Subdural, Chronic trials with similar outcome

NCT02362321 · Phase PHASE4 · May 2009

Browse all Hematoma, Subdural, Chronic trials

A NA clinical study on Hematoma, Subdural, Chronic, this trial is terminated or withdrawn. The trial is conducted by Alice Brenaa Foundation and has accumulated 9 data snapshots since 2009. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

9 versions recorded

Feb 2025 — Present [monthly]

Terminated NA
Sep 2024 — Feb 2025 [monthly]

Terminated NA
Jul 2024 — Sep 2024 [monthly]

Terminated NA
Jan 2023 — Jul 2024 [monthly]

Terminated NA
Dec 2022 — Jan 2023 [monthly]

Terminated NA

▶ Show 4 earlier versions

Jan 2021 — Dec 2022 [monthly]

Terminated NA
Sep 2020 — Jan 2021 [monthly]

Terminated NA
Jun 2018 — Sep 2020 [monthly]

Terminated NA
Jan 2017 — Jun 2018 [monthly]

Terminated NA

First recorded

Jul 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Alice Brenaa Foundation
Odense University Hospital
Overlægerådets legatudvalg
The Hede Nielsen Family Foundation
University of Southern Denmark

Data source: Odense University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.